Blog

featured image of Revolutionizing Protein Purification with AI

Revolutionizing Protein Purification with AI

BIOT

πŸ€– Researchers in Austria 🧬 are using artificial intelligence to describe the 3D structure of therapeutic proteins. πŸ”¬ πŸ“Š The AI helps design processes for purifying advanced therapies during manufacturing βš™οΈ. 🌟 Improve process development and understand protein biology using AI in the future. 🌟

featured image of Revolutionizing Bioprocessing with Chromatogram Shapes

Revolutionizing Bioprocessing with Chromatogram Shapes

BIOT

Discover how Pfizer scientists are leveraging chromatogram shapes to overcome challenges in the bioprocessing industry. πŸ§ͺπŸ‘©β€πŸ”¬πŸ“ˆ

featured image of Revolutionizing Vaccine Development: Faster and Cheaper with Modeling

Revolutionizing Vaccine Development: Faster and Cheaper with Modeling

BIOT

πŸ’‰ Computer modeling techniques can revolutionize the vaccine sector, but harmonized guidelines are crucial for their success.

featured image of Celltrion's Game-Changing 5-Year Partnership Boosts Biotech

Celltrion’s Game-Changing 5-Year Partnership Boosts Biotech

BIOT

πŸ“’ Celltrion taps Prestige Bio in a 5-year CDMO deal, expanding its capabilities and strengthening its global position. πŸ’ΌπŸŒπŸ’ͺπŸ“ˆ

featured image of Streamlining GMP Implementation for Biotech Industry

Streamlining GMP Implementation for Biotech Industry

BIOT

πŸ” Simplifying GMP implementation with a risk-based approach to single-use technology in the biotechnology industry. πŸ’Ό

featured image of Cell and Gene Therapy: $82B Market by 2032 - Trends Challenges and Innovations

Cell and Gene Therapy: $82B Market by 2032 – Trends Challenges and Innovations

BIOT

πŸ“° The global cell and gene therapy market is expected to reach $82.24 billion by 2032, with a current size of $15.54 billion in 2022. - Precedence Research 🧫 πŸ”¬ Gene therapy is seeing a rise in gene editing therapeutics, but cost and access remain challenges. πŸ’‰ πŸ“ˆ Autologous CAR-T cell therapies are moving to earlier treatment stages, while allogeneic cell therapies and solid tumor therapies are being developed. πŸ€– πŸ’Ό Collaboration and flexible regulatory pathways are key to advancing the industry and delivering therapies to patients. πŸ’ͺ

featured image of CordenPharma Revolutionizes Drug Delivery with pHLIP LNP Platform

CordenPharma Revolutionizes Drug Delivery with pHLIP LNP Platform

BIOT

πŸ’Ό CordenPharma partners with pHLIP LNP platform to revolutionize drug delivery and expand capabilities in biotechnology. πŸš€πŸ’ŠπŸ€

featured image of Pluri Revolutionizes Cell Therapy with Expanded CDMO Services

Pluri Revolutionizes Cell Therapy with Expanded CDMO Services

BIOT

🌟 Pluri, a cell therapy pioneer, ventures into the CDMO space, offering end-to-end services for biotech development. πŸš€

featured image of Uncovering the Perfect Price for CGT: A Global Quest

Uncovering the Perfect Price for CGT: A Global Quest

BIOT

πŸŒπŸ’° Global collaboration is essential to strike a balance between affordable and sustainable price points in the CGT industry.

featured image of Sleep Tech Startup Onera Health Raises $32M in Funding

Sleep Tech Startup Onera Health Raises $32M in Funding

BIOT

πŸ“’ Sleep diagnostics specialist Onera Health raises €30m ($32m) in Series C round, accelerating manufacturing and expanding devices. πŸ’€πŸ’°

Previous 1…104105106107108…119 Next